6 Analysts Assess Alkermes: What You Need To Know - Nasdaq

Jul 15, 2024 · Alkermes (NASDAQ: ALKS) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings ...

CouponFollow Extension

$37.14
OFF

7 Analysts Assess Alkermes: What You Need To Know

1 week from now

May 2, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Alkermes, presenting an average target of $37.14, a high estimate of $50.00, and a low estimate of $25.00.

businessinsider.com

$40.29
OFF

Decoding 7 Analyst Evaluations For Alkermes - Nasdaq

1 week from now

Oct 10, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $40.29, a high estimate of $48.00, and a low estimate of $31.00.

nasdaq.com

86%
OFF

A Glimpse Into The Expert Outlook On Alkermes Through 9 …

1 week from now

Nov 5, 2024 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $38.0, a high estimate of $48.00, and a low estimate of $26.00. A 0.86% drop is …

nasdaq.com

28%
OFF

Alkermes Plc (ALKS) Stock Price, Quote & News - Stock Analysis

1 week from now

Nov 1, 2024 · Analyst Forecast. According to 11 analysts, the average rating for ALKS stock is "Buy." The 12-month stock price forecast is $35.0, which is an increase of 21.28% from the …

stockanalysis.com

$40.00
OFF

Alkermes (NASDAQ:ALKS) Given New $40.00 Price Target At …

1 week from now

2 days ago · Alkermes (NASDAQ:ALKS - Get Free Report) had its price target upped by equities research analysts at Mizuho from $35.00 to $40.00 in a note issued to investors on …

marketbeat.com

93%
OFF

Alkermes (ALKS) Outpaces Stock Market Gains: What You Should …

1 week from now

Jan 12, 2024 · Alkermes (ALKS) closed the most recent trading day at $28.20, moving +0.93% from the previous trading session. The stock's change was more than the S&P 500's daily gain …

nasdaq.com

$38
OFF

Breaking Down Alkermes: 5 Analysts Share Their Views

1 week from now

Apr 9, 2024 · Analysts have set 12-month price targets for Alkermes, revealing an average target of $38.0, a high estimate of $50.00, and a low estimate of $25.00. This upward trend is …

businessinsider.com

$31
OFF

Alkermes Price Target Raised To $31 From $28 At BofA - Nasdaq

1 week from now

2 days ago · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer …

nasdaq.com

$45
OFF

6 Analysts Assess JD.com: What You Need To Know

1 week from now

8 hours ago · Analysts have set 12-month price targets for JD.com, revealing an average target of $45.0, a high estimate of $50.00, and a low estimate of $28.00.

benzinga.com

$52.15
OFF

A Closer Look At 13 Analyst Recommendations For HF Sinclair

1 week from now

4 days ago · Insights from analysts' 12-month price targets are revealed, presenting an average target of $52.15, a high estimate of $60.00, and a low estimate of $42.00.

nasdaq.com

$59.17
OFF

6 Analysts Assess Fluor: What You Need To Know | Nasdaq

1 week from now

Oct 22, 2024 · Analysts have set 12-month price targets for Fluor, revealing an average target of $59.17, a high estimate of $66.00, and a low estimate of $51.00. Marking an increase of …

nasdaq.com

$109.83
OFF

12 Analysts Assess Alibaba Gr Hldgs: What You Need To Know

1 week from now

3 days ago · Insights from analysts' 12-month price targets are revealed, presenting an average target of $109.83, a high estimate of $137.00, and a low estimate of $85.00.

nasdaq.com

FAQs about 6 Analysts Assess Alkermes: What You Need To Know - Nasdaq Coupon?

How do analysts evaluate Alkermes (Alkermes) stock?

Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Alkermes's stock. This comparison reveals trends in analysts' expectations over time. To gain a panoramic view of Alkermes's market performance, explore these analyst evaluations alongside essential financial indicators. ...

How can I view Alkermes's market performance?

To gain a panoramic view of Alkermes's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table. Stay up to date on Alkermes analyst ratings. ...

How much should you buy Alkermes (Alkermes)?

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for Alkermes, revealing an average target of $38.0, a high estimate of $50.00, and a low estimate of $25.00. ...

How do financial analysts perceive Alkermes?

The perception of Alkermes by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. ...

What does Alkermes do?

Stay informed and make data-driven decisions with our Ratings Table. Stay up to date on Alkermes analyst ratings. Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. ...

Why do analysts'maintain' or 'raise' their stance on Alkermes?

Analysts maintain or raise their stance on Alkermes in response to changes in market conditions and company performance. Their actions reflect their reaction to recent developments related to Alkermes. ...